| Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms H Slika, H Mansour, N Wehbe, SA Nasser, R Iratni, G Nasrallah, A Shaito, ... Biomedicine & Pharmacotherapy 146, 112442, 2022 | 265 | 2022 |
| Novel differential neuroproteomics analysis of traumatic brain injury in rats FH Kobeissy, AK Ottens, Z Zhang, MC Liu, ND Denslow, JR Dave, ... Molecular & Cellular Proteomics 5 (10), 1887-1898, 2006 | 238 | 2006 |
| Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products Z Zhang, JS Zoltewicz, S Mondello, KJ Newsom, Z Yang, B Yang, ... PloS one 9 (3), e92698, 2014 | 230 | 2014 |
| Brain neurotrauma: molecular, neuropsychological, and rehabilitation aspects FH Kobeissy Crc Press, 2015 | 228 | 2015 |
| Ubiquitin C‐terminal hydrolase‐L1 as a biomarker for ischemic and traumatic brain injury in rats MC Liu, L Akinyi, D Scharf, J Mo, SF Larner, U Muller, MW Oli, W Zheng, ... European Journal of Neuroscience 31 (4), 722-732, 2010 | 200 | 2010 |
| Protein biomarkers and neuroproteomics characterization of microvesicles/exosomes from human cerebrospinal fluid following traumatic brain injury R Manek, A Moghieb, Z Yang, D Kumar, F Kobessiy, GA Sarkis, ... Molecular neurobiology 55, 6112-6128, 2018 | 161 | 2018 |
| AutoDock and AutoDockTools for protein-ligand docking: beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a case study N El-Hachem, B Haibe-Kains, A Khalil, FH Kobeissy, G Nemer Neuroproteomics: Methods and Protocols, 391-403, 2017 | 152 | 2017 |
| Calpain-mediated collapsin response mediator protein-1,-2, and-4 proteolysis after neurotoxic and traumatic brain injury Z Zhang, AK Ottens, S Sadasivan, FH Kobeissy, T Fang, RL Hayes, ... Journal of neurotrauma 24 (3), 460-472, 2007 | 151 | 2007 |
| Food addiction and obesity: evidence from bench to bedside Y Liu, KM von Deneen, FH Kobeissy, MS Gold Journal of psychoactive drugs 42 (2), 133-145, 2010 | 150 | 2010 |
| Glycosylation changes in brain cancer L Veillon, C Fakih, H Abou-El-Hassan, F Kobeissy, Y Mechref ACS chemical neuroscience 9 (1), 51-72, 2018 | 140 | 2018 |
| CREB phosphorylation regulates striatal transcriptional responses in the self-administration model of methamphetamine addiction in the rat IN Krasnova, M Chiflikyan, Z Justinova, MT McCoy, B Ladenheim, ... Neurobiology of disease 58, 132-143, 2013 | 135 | 2013 |
| Methamphetamine-and trauma-induced brain injuries: comparative cellular and molecular neurobiological substrates MS Gold, FH Kobeissy, KKW Wang, LJ Merlo, AW Bruijnzeel, IN Krasnova, ... Biological psychiatry 66 (2), 118-127, 2009 | 124 | 2009 |
| The challenge of mild traumatic brain injury: role of biochemical markers in diagnosis of brain damage S Mondello, K Schmid, RP Berger, F Kobeissy, D Italiano, A Jeromin, ... Medicinal research reviews 34 (3), 503-531, 2014 | 122 | 2014 |
| Combining biochemical and imaging markers to improve diagnosis and characterization of mild traumatic brain injury in the acute setting: results from a pilot study Z Kou, R Gattu, F Kobeissy, RD Welch, BJ O’Neil, JL Woodard, SI Ayaz, ... PloS one 8 (11), e80296, 2013 | 122 | 2013 |
| Assessment of serum UCH-L1 and GFAP in acute stroke patients C Ren, F Kobeissy, A Alawieh, N Li, N Li, K Zibara, S Zoltewicz, ... Scientific reports 6 (1), 1-9, 2016 | 121 | 2016 |
| Serum concentrations of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein after pediatric traumatic brain injury S Mondello, F Kobeissy, A Vestri, RL Hayes, PM Kochanek, RP Berger Scientific reports 6 (1), 28203, 2016 | 117 | 2016 |
| Traumatic brain injury: oxidative stress and novel anti-oxidants such as mitoquinone and edaravone H Ismail, Z Shakkour, M Tabet, S Abdelhady, A Kobaisi, R Abedi, ... Antioxidants 9 (10), 943, 2020 | 113 | 2020 |
| Characteristics and impact of US military blast-related mild traumatic brain injury: a systematic review H Phipps, S Mondello, A Wilson, T Dittmer, NN Rohde, PJ Schroeder, ... Frontiers in neurology 11, 559318, 2020 | 108 | 2020 |
| Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase ED AlFadly, PA Elzahhar, A Tramarin, S Elkazaz, H Shaltout, ... European journal of medicinal chemistry 167, 161-186, 2019 | 98 | 2019 |
| SARS-CoV-2 and stroke characteristics: a report from the multinational COVID-19 stroke study group S Shahjouei, G Tsivgoulis, G Farahmand, E Koza, A Mowla, A Vafaei Sadr, ... Stroke 52 (5), e117-e130, 2021 | 97 | 2021 |
Kevin K.W. Wang_University of Florida, Banyan Biomarkers, Gryphon Bio, University of British Columbia, UniversityVerified email at ufl.edu
